PDS-2™ mentioned in Medical Device And Diagnostic Industry, Apr 19, 2021
PDS-2™ System Pivotal Trial Results Published in the Journal of American College of Cardiology, Dec 22, 2020.Download
HDL Therapeutics Registration Trial of PDS-2™ System in Homozygous Familial Hypercholesterolemia Selected as a 2019 Best of American Heart Association Specialty Conference Presentation, Nov 17 2019Download
HDL Therapeutics Announces Positive Data From Registration Trial of PDS-2™ System in Homozygous Familial Hypercholesterolemia: May 15 2019Download
Coronary Atheroma Regression from Serial Infusions of Autologous Selectively Delipidated Preβ-HDL-enriched Plasma on Coronary Atheroma in Patients With Homozygous Familial Hypercholesterolemia in the HALO-FH TrialDownload
American Heart Association’s Vascular Discovery: From Genes to Medicine Scientific Sessions May 15 2019
A First in Man, Randomized, Placebo Controlled Study to Evaluate the Safety and Feasibility of Autologous Delipidated High Density Lipoprotein Plasma Infusions in Patients With Acute Coronary SyndromeDownload
Journal of The American College of Cardiology. 15:55:2727-2735. 2010. Waksman, Brewer, et al.
Journal of Lipid Research. 50:894-907.2009. Sacks, Brewer, et al.